Vertex Pharmaceuticals Lifts FY21 Revenue Outlook

Vertex Pharmaceuticals Inc. (VRTX) lifts its full year 2021 revenue outlook. The company now expects revenues of $7.2 billion to $7.4 billion for the full year 2021.

Analysts polled by Thomson Reuters currently expect revenues of $6.99 billion for the year. Previously, the company expected revenues of $6.7 billion to $6.9 billion.

Meanwhile, the company maintained its outlook for combined R&D and SG&A expenses for the full year of $3.8 billion to $3.95 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Buena, New Jersey-based Teligent Pharma, Inc. is recalling two lots of Lidocaine HCl Topical Solution USP 4%, 50ml to the user level due to super potency, the U.S. Food and Drug Administration said. The product is indicated for the production of topical anesthesia of accessible mucous membranes of the oral and nasal cavities and proximal portions of the digestive tract. Meta Platforms Inc., the parent of Facebook, Instagram, and WhatsApp, said it is launching more options on WhatsApp to control their messages and how long they stick around, with default disappearing messages and multiple durations. The latest features are expected to bring more control and privacy on the popular messaging app. Delivery services company DoorDash has introduced ultra-fast grocery deliveries with DashMart in Chelsea, New York City. The company said it aims to deliver in 10-15 minutes and plans to expand its new service in select DoorDash grocery and convenience partners over the next year. With over 2,000 items, DashMart offers a wide assortment of fresh and frozen grocery staples, snacks, household goods, and local products.
Follow RTT